相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent therapeutic approaches to cystathionine beta-synthase-deficient homocystinuria
Tomas Majtan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2023)
The diagnostic challenge of mild citrulline elevation at newborn screening
Barbara Siri et al.
MOLECULAR GENETICS AND METABOLISM (2022)
Phenylketonuria oxidative stress and energy dysregulation: Emerging pathophysiological elements provide interventional opportunity
Steven F. Dobrowolski et al.
MOLECULAR GENETICS AND METABOLISM (2022)
A Silk-Based Platform to Stabilize Phenylalanine Ammonia-lyase for Orally Administered Enzyme Replacement Therapy
Luciana d'Amone et al.
MOLECULAR PHARMACEUTICS (2022)
Homocystinuria diagnosis and management: it is not all classical
Adam Gerrard et al.
JOURNAL OF CLINICAL PATHOLOGY (2022)
Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model
Ramon Diaz-Trelles et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2022)
Cystathionine β-synthase deficiency in the E-HOD registry-part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis
Viktor Kozich et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2021)
Insights from Animal Models on the Pathophysiology of Hyperphenylalaninemia: Role of Mitochondrial Dysfunction, Oxidative Stress and Inflammation
Angela T. S. Wyse et al.
MOLECULAR NEUROBIOLOGY (2021)
Immune Dysregulation Mimicking Systemic Lupus Erythematosus in a Patient With Lysinuric Protein Intolerance: Case Report and Review of the Literature
Josefina Longeri Contreras et al.
FRONTIERS IN PEDIATRICS (2021)
Milestones in treatments for inborn errors of metabolism: Reflections on Where chemistry and medicine meet
Hilary J. Vernon et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)
Long-term functional correction of cystathionine beta-synthase deficiency in mice by adeno-associated viral gene therapy
Hyung-Ok Lee et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2021)
Phenylketonuria
Francjan J. van Spronsen et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Early Development of Newborn Screening for HCU and Current Challenges
Harvey L. Levy
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2021)
Robert Guthrie and the Trials and Tribulations of Newborn Screening
Harvey L. Levy
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2021)
Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia
Bijina Balakrishnan et al.
MOLECULAR THERAPY (2020)
Estimated prevalence of moderate to severely elevated total homocysteine levels in the United States: A missed opportunity for diagnosis of homocystinuria?
Marcia Sellos-Moura et al.
MOLECULAR GENETICS AND METABOLISM (2020)
CUGC for lysinuric protein intolerance (LPI)
Diego Martinelli et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2020)
The Genetic Landscape and Epidemiology of Phenylketonuria
Alicia Hillert et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2020)
A global Slc7a7 knockout mouse model demonstrates characteristic phenotypes of human lysinuric protein intolerance
Bridget M. Stroup et al.
HUMAN MOLECULAR GENETICS (2020)
Sustained Correction of a Murine Model of Phenylketonuria following a Single Intravenous Administration of AAVHSC15-PAH
Seemin S. Ahmed et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
What Constitutes a Gluconeogenic Precursor?
Mark A. Tetrick et al.
JOURNAL OF NUTRITION (2020)
Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up
Barbara K. Burton et al.
MOLECULAR GENETICS AND METABOLISM (2020)
Metabolic Serendipities of Expanded Newborn Screening
Raquel Yahyaoui et al.
GENES (2020)
Analysis of LPI-causing mutations on y+LAT1 function and localization
Bianca Maria Rotoli et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
State-of-the-Art 2019 on Gene Therapy for Phenylketonuria
Hiu Man Grisch-Chan et al.
HUMAN GENE THERAPY (2019)
Overview of symptoms and treatment for lysinuric protein intolerance
Atsuko Noguchi et al.
JOURNAL OF HUMAN GENETICS (2019)
Inducible Slc7a7 Knockout Mouse Model Recapitulates Lysinuric Protein Intolerance Disease
Susanna Bodoy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Classical homocystinuria: From cystathionine beta-synthase deficiency to novel enzyme therapies
Erez M. Bublil et al.
BIOCHIMIE (2019)
Tetrahydrobipterin-responsive phenylalanine hydroxylase deficiency
Shigeo Kure et al.
JOURNAL OF HUMAN GENETICS (2019)
Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human Primates
Xuling Zhu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Hemophagocytic Lymphohistiocytosis
Hanny Al-Samkari et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)
Janet Thomas et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Phenylalanine ammonia lyase (PAL): From discovery to enzyme substitution therapy for phenylketonuria
Harvey L. Levy et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Relationship between genotype, phenylalanine hydroxylase expression and in vitro activity and metabolic phenotype in phenylketonuria
Nastassja Himmelreich et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study
Nicola Longo et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia (vol 21, pg 3548, 2017)
Ding An et al.
CELL REPORTS (2018)
The Effects of Homocysteine on the Skeleton
Mitsuru Saito et al.
CURRENT OSTEOPOROSIS REPORTS (2018)
Treatment of a metabolic liver disease by in vivo genome base editing in adult mice
Lukas Villiger et al.
NATURE MEDICINE (2018)
Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence
Donald Waters et al.
JOURNAL OF GLOBAL HEALTH (2018)
Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency
Andrew A. M. Morris et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Update on Lysinuric Protein Intolerance, a Multi-faceted Disease Retrospective cohort analysis from birth to adulthood
Wladimir Mauhin et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
DNAJC12 and dopa-responsive nonprogressive parkinsonism
Letizia Straniero et al.
ANNALS OF NEUROLOGY (2017)
Amino acid homeostasis and signalling in mammalian cells and organisms
Stefan Broer et al.
BIOCHEMICAL JOURNAL (2017)
Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual Disability
Yair Anikster et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Low bone mineral density is a common finding in patients with homocystinuria
David R. Weber et al.
MOLECULAR GENETICS AND METABOLISM (2016)
Dysfunction in macrophage toll-like receptor signaling caused by an inborn error of cationic amino acid transport
Johanna Kurko et al.
MOLECULAR IMMUNOLOGY (2015)
Lung involvement in children with lysinuric protein intolerance
Sarah Valimahamed-Mitha et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2015)
High prevalence of cerebral venous sinus thrombosis (CVST) as presentation of cystathionine beta-synthase deficiency in childhood: Molecular and clinical findings of Turkish probands
Mehmet Karaca et al.
GENE (2014)
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
Jerry Vockley et al.
GENETICS IN MEDICINE (2014)
Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias
Nenad Blau
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature: proper classification and nomenclature
Saskia B. Wortmann et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
A diversified approach for PKU treatment: Routine screening yields high incidence of psychiatric distress in phenylketonuria clinics
Barbara K. Burton et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Long-term Follow-up and Outcome of Phenylketonuria Patients on Sapropterin: A Retrospective Study
Stefanie Keil et al.
PEDIATRICS (2013)
Exploring the transcriptomic variation caused by the Finnish founder mutation of lysinuric protein intolerance (LPI)
Maaria Tringham et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Impaired phagocytosis in macrophages from patients affected by lysinuric protein intolerance
Amelia Barilli et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Lysinuric protein intolerance (LPI): A multi organ disease by far more complex than a classic urea cycle disorder
Helene Ogier de Baulny et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria
Lihi Adler-Abramovich et al.
NATURE CHEMICAL BIOLOGY (2012)
Lysinuric Protein Intolerance: Reviewing Concepts on a Multisystem Disease
Gianfranco Sebastio et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2011)
Vascular presentation of cystathionine beta-synthase deficiency in adulthood
Martin Magner et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Neurological complications and behavioral problems in patients with phenylketonuria in a Follow-up Unit
Maria J. Gonzalez et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies
Nenad Blau et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Newborn Population Screening for Classic Homocystinuria by Determination of Total Homocysteine from Guthrie Cards
Hongying Gan-Schreier et al.
JOURNAL OF PEDIATRICS (2010)
Effects of phenylalanine on the survival and neurite outgrowth of rat cortical neurons in primary cultures: possible involvement of brain-derived neurotrophic factor
Duan Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria
H. J. Vernon et al.
MOLECULAR GENETICS AND METABOLISM (2010)
A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency
Flemming Skovby et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Psychiatric symptoms and disorders in phenylketonuria
V. L. Brumm et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Amino acids: metabolism, functions, and nutrition
Guoyao Wu
AMINO ACIDS (2009)
Carnitine deficiency and L-carnitine supplementation in lysinuric protein intolerance
Laura M. Tanner et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Lysinuric protein intolerance: Update and extended mutation analysis of the SLC7A7 gene
Maria Pia Sperandeo et al.
HUMAN MUTATION (2008)
Chemical chaperone rescue of mutant human cystathionine β-synthase
Laishram R. Singh et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Slc7a7 disruption causes fetal growth retardation by downregulating Igf1 in the mouse model of lysinuric protein intolerance
Maria Pia Sperandeo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Nephropathy advancing to end-stage renal disease: A novel complication of lysinuric protein intolerance
Laura M. Tanner et al.
JOURNAL OF PEDIATRICS (2007)
Mechanisms of homocysteine toxicity in humans
J. Perla-Kajan et al.
AMINO ACIDS (2007)
Successful treatment of pyridoxine-unresponsive homocystinuria with betaine in pregnancy
Germaine Pierre et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
A y+LAT-1 mutant protein interferes with y+LAT-2 activity:: implications for the molecular pathogenesis of lysinuric protein intolerance
MP Sperandeo et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2005)
Increased NO production in lysinuric protein intolerance
L Mannucci et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Cerebral edema associated with betaine treatment in classical homocystinuria
AM Devlin et al.
JOURNAL OF PEDIATRICS (2004)
Cystathionine β-synthase:: Structure, function, regulation, and location of homocystinuria-causing mutations
EW Miles et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Homocysteine levels and the risk of osteoporotic fracture
JBJ van Meurs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Evaluation of a mass screening program for lysinuric protein intolerance in the northern part of Japan
A Koizumi et al.
GENETIC TESTING (2003)
Stroke in young patients with hyperhomocysteinemia due to cystathionine beta-synthase deficiency
PJ Kelly et al.
NEUROLOGY (2003)
Deficits in brain serotonin synthesis in a genetic mouse model of phenylketonuria
T Pascucci et al.
NEUROREPORT (2002)
Oxidative stress in a phenylketonuria animal model
N Ercal et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Experimental hyperphenylalaninemia provokes oxidative stress in rat brain
MEK Hagen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Expression of normal and mutant GFP-tagged y+L amino acid transporter-1 in mammalian cells
M Toivonen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine β-synthase (CBS) deficiency
R Yaghmai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine beta-synthase (CBS) mutations
KN Maclean et al.
HUMAN MUTATION (2002)
The molecular basis of cystathionine beta-synthase deficiency in Australian patients: Genotype-phenotype correlations and response to treatment
M Gaustadnes et al.
HUMAN MUTATION (2002)
Vascular outcome in patients with homocystinuria due to cystathionine β-synthase deficiency treated chronically -: A multicenter observational study
S Yap et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Function and structure of heterodimeric amino acid transporters
CA Wagner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)
Ocular findings among patients with late-diagnosed or poorly controlled homocystinuria compared with a screened, well-controlled population
A Mulvihill et al.
JOURNAL OF AAPOS (2001)
The neuropathology of phenylketonuria: human and animal studies
PR Huttenlocher
EUROPEAN JOURNAL OF PEDIATRICS (2000)
Functional analysis of novel mutations in y+LAT-1 amino acid transporter gene causing lysinuric protein intolerance (LPI)
J Mykkänen et al.
HUMAN MOLECULAR GENETICS (2000)
Dramatic brain aminergic deficit in a genetic mouse model of phenylketonuria
S Puglisi-Allegra et al.
NEUROREPORT (2000)
Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance
MP Sperandeo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
分享论文
